Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Table 6 Analysis of factors associated with placental malaria by microscopy among delivering women

Variable	Placental malaria (PM)		Crude OR	P-value	Adjusted OR	P-value
	N	No. PM positive (%)	(95% CI)		(95% CI)
Maternal Age
<20 years	97	42 (43.30)	1.36 (0.86, 2.16)	0.188	1.08 (0.62, 1.89	0.790
≥20 years	334	120 (35.93)	Reference		Reference
Ethnicity
Sukuma/Zinza	309	122 (39.48)	1.34 (0.86, 2.08)	0.197	1.18 (0.74, 1.89)	0.489
Other Tribes	122	40 (32.79	Reference		Reference
Health facility
Geita hospital	265	93 (35.09)	Reference		Reference
Katoro HC	166	69 (41.57)	1.32 (0.88, 1.96)	0.177	1.29 (0.84, 1.98)	0.239
Gravidity
Paucigravidae	227	94 (41.41)	1.41 (0.95, 2.09)	0.084	1.43 (0.89, 2.30)	0.135
Multigravidae	204	68 (33.33)	Reference		Reference
SP receipt
<3 doses	405	158 (39.01)	Reference		Reference
≥3 doses	26	4 (15.38)	0.28 (0.10, 0.84)	0.023	0.31 (0.10, 0.94)	0.039
Bed net use
No	10	6 (60.00)	2.48 (0.69, 8.92)	0.165	2.53 (0.69, 9.26)	0.159
Yes	403	152 (37.72)	Reference		Reference

HC = health centre; OR = odds ratio, 95% CI = 95% confidence interval, PM = placental malaria; SP = sulphadoxine-pyrimethamine; Significant p-values are presented in bold.

ISSN: 1475-2875